16-5025653-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016256.4(NAGPA):āc.1373C>Gā(p.Ala458Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,612,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016256.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152192Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000245 AC: 6AN: 245052Hom.: 0 AF XY: 0.00000752 AC XY: 1AN XY: 133054
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460786Hom.: 0 Cov.: 35 AF XY: 0.00000550 AC XY: 4AN XY: 726676
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152192Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2024 | The c.1373C>G (p.A458G) alteration is located in exon 10 (coding exon 10) of the NAGPA gene. This alteration results from a C to G substitution at nucleotide position 1373, causing the alanine (A) at amino acid position 458 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at